Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 4, Pages 946-957
Publisher
Springer Nature
Online
2014-01-03
DOI
10.1038/bjc.2013.789
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group
- (2012) Alexander Baraniskin et al. Clinical Colorectal Cancer
- Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
- (2012) A. D. Roth et al. JNCI-Journal of the National Cancer Institute
- Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
- (2011) P. Papageorgis et al. CANCER RESEARCH
- 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation
- (2011) Guopei Zheng et al. FEBS LETTERS
- Smad4-Mediated Signaling Inhibits Intestinal Neoplasia by Inhibiting Expression of β-Catenin
- (2011) Tanner J. Freeman et al. GASTROENTEROLOGY
- Smad4 May Help to Identify a Subset of Colorectal Cancer Patients with Early Recurrence after Curative Therapy
- (2011) Byung Kyu Ahn et al. HEPATO-GASTROENTEROLOGY
- Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways
- (2011) Qiang Chen et al. HEPATOLOGY
- LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells
- (2010) Jung-Young Shin et al. BMC CANCER
- Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells
- (2010) S Samuel et al. ONCOGENE
- Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
- (2009) T Noda et al. BRITISH JOURNAL OF CANCER
- Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
- (2009) Bixiang Zhang et al. CANCER LETTERS
- Antimetastatic Role of Smad4 Signaling in Colorectal Cancer
- (2009) Bixiang Zhang et al. GASTROENTEROLOGY
- Effective Treatment of Advanced Colorectal Cancer by Rapamycin and 5-FU/Oxaliplatin Monitored by TIMP-1
- (2009) Markus Wagner et al. JOURNAL OF GASTROINTESTINAL SURGERY
- A metastatic colon cancer model using nonoperative transanal rectal injection
- (2009) Melissa Donigan et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling
- (2008) I Ischenko et al. ONCOGENE
- Akt Regulates Drug-Induced Cell Death through Bcl-w Downregulation
- (2008) Michela Garofalo et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started